Robert M. Joynes


Robert M. Joynes

  • P 202-721-8203
  • F 202-721-8250

Robert Joynes focuses his practice on preparing and prosecuting U.S. patent applications on behalf of domestic and foreign clients in the chemical, biotechnology and pharmaceutical arts. In addition, Robert provides opinions to clients on patentability, validity and clearance matters.

Specifically, Robert's practice encompasses a wide range of technologies including:

  • Pharmaceutical formulations and methods of use
  • Food compositions
  • Antibodies
  • Vaccines
  • Nanotechnologies
  • Extracts
  • Diagnostic agents and methods of use
  • Cosmetic compositions
  • Lipid and liposome technologies
  • Resin compositions
  • Detection methods in biological samples
  • Small molecule chemistry
  • Electrodeposition coatings and methods of forming the coatings
  • Cell culture technologies
  • Array devices and methods of use
  • Polymer compositions for use in optics

Prior to joining Wenderoth, Robert worked at the United States Patent and Trademark Office as a Patent Examiner. Additionally, Robert worked at the National Institutes of Health in the Office of Technology Transfer. Furthermore, Robert worked at both Nath, Goldberg & Meyer and Plumsea Law Group prior to joining the firm.

When not practicing law, Robert enjoys exploring the world around him through the lens of his camera. In addition, Robert enjoys time with his family and supporting his favorite sports teams.

  • Lecturer for the Foundation for Advanced Education in the Sciences (FAES) Technology Transfer class
  • Hungarian Biotechnology Association Biomanager Training meeting, Pecs, Hungary 2006
  • (Coauthor) "The High Standard for Inherency: Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc.," Chemical Practices Chronicles - Quarterly Newsletter of the AIPLA Chemical Committee, Janaury 30, 2015.